Please review the guidance below from the Mississippi State Board of Medical Licensure:
Guidance regarding GLP-1 and GIP medications
Semaglutide Guidance 08-29-2023
MSBML Guidance for Licensees
Key Links
- Licensure Gateway
- Online Services
- Board Meetings
- Board Meeting Minutes
- Board Actions
- CE Broker
- Regulation Proposals and Filings
- Prescribing Regulations
- Interstate Licensure Compact
- General Information
- Declaratory Opinions
- Compliance CME Providers
- MSMA CME
- Approved Competency Assessment Facilities
- Resource Links
- FAQ's (for licensees)
- POST Form
- RX Monitoring Program
- Dropbox Login
- Web Mail